Mortality rates of as much as 20% for the cutaneous form, 60 to 80% for the GI form, and 90 to 99% for the pulmonary form make prompt treatment essential [33] . With multi-drug antibiotic regimens and supportive care, survival rates have improved. If there is a delay in treatment initiation from 2 to 4.8 days, the mortality would be expected to double [34] .